1. Home
  2. RYN vs RGEN Comparison

RYN vs RGEN Comparison

Compare RYN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rayonier Inc. REIT

RYN

Rayonier Inc. REIT

HOLD

Current Price

$21.04

Market Cap

6.4B

Sector

Real Estate

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$126.57

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYN
RGEN
Founded
1926
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.6B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
RYN
RGEN
Price
$21.04
$126.57
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$26.00
$167.67
AVG Volume (30 Days)
2.4M
928.9K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
11.73%
N/A
EPS Growth
26.78
286.96
EPS
N/A
0.15
Revenue
$484,485,000.00
$141,236,000.00
Revenue This Year
$214.97
$14.30
Revenue Next Year
$10.35
$14.52
P/E Ratio
N/A
$880.13
Revenue Growth
N/A
35.10
52 Week Low
$19.49
$100.99
52 Week High
$27.34
$175.77

Technical Indicators

Market Signals
Indicator
RYN
RGEN
Relative Strength Index (RSI) 51.46 51.33
Support Level $20.99 $111.09
Resistance Level $21.57 $131.53
Average True Range (ATR) 0.53 5.57
MACD 0.02 0.27
Stochastic Oscillator 34.17 42.86

Price Performance

Historical Comparison
RYN
RGEN

About RYN Rayonier Inc. REIT

Rayonier Inc is a timberland real estate investment trust engaged in the ownership, management, and investment of timberlands. The company operates through Southern Timber, Pacific Northwest Timber, and Real Estate segments. The Southern Timber and Pacific Northwest Timber segments are involved in harvesting timber and related activities, as well as value-added services such as licensing properties for hunting, leasing land for mineral extraction and communication infrastructure, land-based solutions including carbon capture and solar energy, and log trading. The Real Estate segment is engaged in land sales across various categories, as well as residential and commercial leasing activities. It generates the majority of its revenue from the Southern Timber segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: